14 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
anticoagulants (DOACs ... and prevention - Comparison ... Table #DOAC ... #Pharmacology #Comparison ... #Table
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison ... #Table #Pharmacology
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Warfarin and DOAC ... h) #Warfarin #DOAC ... #Pharmacology #NOAC ... #comparison #table
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
2017 AHA/ACC VHD Guidelines ... anticoagulants (DOACs ... 2017 AHA/ACC VHD Guidelines ... #INR #Target #DOAC ... #Table #Replacement
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... #medications #doac ... #comparison #table
POCUS Echocardiography - Table of Cardiac Views and Windows
 • Parastemal Long-Axis View (PLAX)
 • Parasternal
POCUS Echocardiography ... - Table of Cardiac ... Doppler #Anatomy #POCUS ... Orientations #Atlas #Map #Comparison ... #Table #Echocardiography
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
LMWH, warfarin, DOACs ... Deficiencies #Summary #table ... #comparison #diagnosis
Main Lung Ultrasound differences between COVID-19 involvement and other conditions that may yield respiratory symptoms
 •
areas #COVID19 #POCUS ... Lung #Ultrasound #Comparison ... #Table #Diagnosis
Appearance of Liver Lesions on Various Imaging Modalities
 • Computed Tomography (CT) - Arterial Phase, Portal
Contrast #CT #MRI #POCUS ... differential #diagnosis #comparison ... #table #appearance
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... during Delivery • Stable ... e.g., <50%), ESC guidelines